These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35644565)

  • 1. Pan-Driver-Negatives versus Epidermal Growth Factor Receptor Mutants for C-Stage IA Lung Adenocarcinoma with Ground-Glass Opacity.
    Li M; Xi J; Zhang H; Jin X; Zhang J; Feng M; Zhan C; Wang Q
    Ann Thorac Cardiovasc Surg; 2022 Oct; 28(5):320-328. PubMed ID: 35644565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of epidermal growth factor receptor-mutated stage I lung adenocarcinoma with radiologically solid features.
    Hattori A; Matsunaga T; Fukui M; Takamochi K; Suzuki K
    Eur J Cardiothorac Surg; 2022 Mar; 61(4):769-777. PubMed ID: 34791156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncological characteristics of epidermal growth factor receptor-mutated clinical stage IA lung adenocarcinoma with radiologically pure-solid appearance.
    Hattori A; Matsunaga T; Fukui M; Tomita H; Takamochi K; Suzuki K
    J Thorac Cardiovasc Surg; 2024 Sep; 168(3):685-696.e2. PubMed ID: 37995863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a Ground-glass Opacity Component on c-Stage IA Lung Adenocarcinoma.
    Li M; Xi J; Sui Q; Kuroda H; Hamanaka K; Bongiolatti S; Hong G; Zhan C; Feng M; Wang Q; Tan L
    Semin Thorac Cardiovasc Surg; 2023 Winter; 35(4):783-795. PubMed ID: 35907612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic influence of epidermal growth factor receptor mutation and radiological ground glass appearance in patients with early-stage lung adenocarcinoma.
    Aokage K; Miyoshi T; Wakabayashi M; Ikeno T; Suzuki J; Tane K; Samejima J; Tsuboi M
    Lung Cancer; 2021 Oct; 160():8-16. PubMed ID: 34365179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Study of Surgical Treated Lung Adenocarcinoma with Ground Glass Nodule Component.
    Xu Y; Zheng M; Wang N; Wang R
    Med Sci Monit; 2019 Nov; 25():8492-8498. PubMed ID: 31710020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minor (≤ 10%) Ground-Glass Opacity Component in Clinical Stage I Non-Small Cell Lung Cancer: Associations With Pathologic Characteristics and Clinical Outcomes.
    Li M; Wang J; Bao X; Wang F; Zhou F; Song N; Wan Z; Li W; Zhang L
    AJR Am J Roentgenol; 2024 Aug; 223(2):e2431283. PubMed ID: 38809121
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination of epidermal growth factor receptor mutation and the presence of high-grade patterns is associated with recurrence in resected stage I lung adenocarcinoma.
    Kondo Y; Ichinose J; Ninomiya H; Hashimoto K; Matsuura Y; Nakao M; Ishikawa Y; Okumura S; Satoh Y; Mun M
    Interact Cardiovasc Thorac Surg; 2022 Jul; 35(2):. PubMed ID: 35266536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Impact of Very Small Ground-Glass Opacity Component in Stage IA Solid Predominant Non-small Cell Lung Cancer.
    Hattori A; Matsunaga T; Fukui M; Suzuki K; Takamochi K; Suzuki K
    Semin Thorac Cardiovasc Surg; 2024 Summer; 36(2):251-260. PubMed ID: 36180013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impacts of EGFR mutation status and subtype in patients with surgically resected lung adenocarcinoma.
    Takamochi K; Oh S; Matsunaga T; Suzuki K
    J Thorac Cardiovasc Surg; 2017 Nov; 154(5):1768-1774.e1. PubMed ID: 28826599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic influence of a ground-glass opacity component in hypermetabolic lung adenocarcinoma.
    Hattori A; Matsunaga T; Fukui M; Takamochi K; Suzuki K
    Eur J Cardiothorac Surg; 2022 Jan; 61(2):249-256. PubMed ID: 34632486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Clinical Stage I Lung Adenocarcinoma.
    Yang F; Sun K; Li F; Li X; Shi J; Sun X; Hong Y; Jiang G; Zhu Y; Song X
    Ann Thorac Surg; 2024 Jun; 117(6):1111-1119. PubMed ID: 37353101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct Clinicopathologic Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical Stage IA Lung Adenocarcinoma.
    Hattori A; Hirayama S; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
    J Thorac Oncol; 2019 Feb; 14(2):265-275. PubMed ID: 30368010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resected lung adenocarcinoma with lymph node metastasis: is ground glass opacity component a prognostic factor?
    Deng C; Jiang C; Ma X; Fu F; Wang S; Li Y; Zhang Y; Chen H
    Transl Lung Cancer Res; 2024 Jul; 13(7):1609-1619. PubMed ID: 39118885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Prognostic Value of Vascular Invasion in Resected Lung Adenocarcinomas According to Epidermal Growth Factor Receptor Mutational Status.
    Lee KH; Chung JH; Cho S; Lee JS; Kim H
    Clin Lung Cancer; 2023 Nov; 24(7):e291-e299.e1. PubMed ID: 37479587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiogenomic correlation in lung adenocarcinoma with epidermal growth factor receptor mutations: Imaging features and histological subtypes.
    Hong SJ; Kim TJ; Choi YW; Park JS; Chung JH; Lee KW
    Eur Radiol; 2016 Oct; 26(10):3660-8. PubMed ID: 26787602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors of Recurrence in Patients With Clinical Stage IA Adenocarcinoma Presented as Ground-Glass Nodule.
    Su H; Dai C; Xie H; Ren Y; She Y; Kadeer X; Xie D; Zheng H; Jiang G; Chen C
    Clin Lung Cancer; 2018 Sep; 19(5):e609-e617. PubMed ID: 29803575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the prognostic implication of ground-glass opacity on CT according to pathological nodal status in lung cancers treated with lobectomy or pneumonectomy.
    Park S; Lee SM; Choe J; Choi S; Kim S; Do KH; Seo JB
    Eur Radiol; 2022 Jul; 32(7):4405-4413. PubMed ID: 35141781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implication of consolidation-to-tumor ratio in early lung adenocarcinoma: a retrospective cross-sectional study.
    Jing W; Liu M; Li W; Li D; Wu Y; Lv F
    Quant Imaging Med Surg; 2024 May; 14(5):3366-3380. PubMed ID: 38720835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.